Product Information
LOTEMAX 0.5% OPHTHALMIC GEL is a brand product labeled by Bausch & Lomb Incorporated, priced at $49.6190 per GM under NDC 24208050307. Its NADAC has been published 665 times since Nov 28, 2013.
FDA first approved this application on Sep 28, 2012. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the loteprednol etabonate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
5 mg/g
Manufacturer
Bausch & Lomb IncorporatedNDC
24208050307
Classification
Brand
Dosage Form
GEL
Route
OPHTHALMIC
Effective Date
8/19/2026
Active Ingredients
LOTEPREDNOL ETABONATEApproval Type
New Drug (NDA)
FDA Application
NDA202872FDA Approved
9/28/2012
TE Code
AB
On Market Since
10/12/2012
Pharmacological Classes
Price Statistics
The NADAC for LOTEMAX 0.5% OPHTHALMIC GEL has been published 665 times since Nov 28, 2013, and over the history we have for it it has risen 110.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $49.6190 per GM |
|---|---|
| All-time high | $49.9549 (May 15, 2024) |
| All-time low | $23.5591 (Nov 28, 2013) |
| 52-week high | $49.7111 |
| 52-week low | $49.5605 |
| Median price | $38.7476 |
| Average price | $38.4587 |
| Largest weekly change | +10.0% (Jan 14, 2015) |
| Weeks tracked | 665 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 68% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of LOTEMAX 0.5% OPHTHALMIC GEL?
The current National Average Drug Acquisition Cost (NADAC) for LOTEMAX 0.5% OPHTHALMIC GEL, manufactured by Bausch & Lomb Incorporated, is $49.6190 per GM (NDC 24208050307), effective Aug 19, 2026.
How has the price of LOTEMAX 0.5% OPHTHALMIC GEL changed over time?
Over the history we have for it, the NADAC for LOTEMAX 0.5% OPHTHALMIC GEL has risen 110.6%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for LOTEMAX 0.5% OPHTHALMIC GEL?
Since Nov 28, 2013, the NADAC for LOTEMAX 0.5% OPHTHALMIC GEL has ranged from a low of $23.5591 (Nov 28, 2013) to a high of $49.9549 (May 15, 2024), with a median of $38.7476 per GM.
Are there cheaper alternatives to LOTEMAX 0.5% OPHTHALMIC GEL?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LOTEPREDNOL 0.5% OPHTHALMC GEL, is $16.0854 per GM — about 68% below LOTEMAX 0.5% OPHTHALMIC GEL.
Who manufactures LOTEMAX 0.5% OPHTHALMIC GEL?
LOTEMAX 0.5% OPHTHALMIC GEL (NDC 24208050307) is labeled by Bausch & Lomb Incorporated, and CMS classifies it as a brand product.